A prospective, randomized, double‐blind, multicentre, parallel‐group, active controlled study to compare efficacy and safety of biosimilar adalimumab (Exemptia; ZRC‐3197) and adali...

por Jani, Rajendrakumar H., Gupta, Rajiv, Bhatia, Girish, Rathi, Gaurav, Ashok Kumar, Patnala, Sharma, Reena, Kumar, Uma, Gauri, Liyakat A., Jadhav, Praveen, Bartakke, Girishchandra, Haridas, Vikram, Jain, Dinesh, Mendiratta, Sanjeev K.
Publicado 2015